The present invention relates to methods of facilitating the expression of recombinant polypeptides from cells, 
extracellular fluids, 
extracellular fibers, or any combination thereof, obtained from transgenic 
insect cells and larvae comprising a bacterial GlcNAc-6-P 2′-epimerase (GNPE), which is capable of converting N-acetyl-D-
glucosamine-6-
phosphate (GlcNAc-6-P) to N-acetyl-D-
mannosamine-6-
phosphate (ManNAc-6-P). The invention relates to methods to promote efficient 
glycoconjugate sialylation, by providing simpler ways to produce large 
intracellular pools of 
sialic acid precursors. The invention is also directed to nucleic acids, vectors, and cells comprising nucleic acids encoding polypeptides involved in the synthesis of 
sialic acid precursors, and cells in combination with nucleic acids encoding glycosyltransferases, including sialyltransferases, to facilitate the production of humanized recombinant glycoproteins. The engineered cells can be used to produce glycosylated proteins lepidopteran insects and 
cultured cell lines derived from 
Spodoptera frugiperda, Trichoplusia ni, and silkworms, such as 
Bombyx mori, particularly those that can be infected by 
baculovirus expression vectors.